0001225208-22-006073.txt : 20220425 0001225208-22-006073.hdr.sgml : 20220425 20220425163328 ACCESSION NUMBER: 0001225208-22-006073 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220421 FILED AS OF DATE: 20220425 DATE AS OF CHANGE: 20220425 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hait William CENTRAL INDEX KEY: 0001904791 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-03215 FILM NUMBER: 22850106 MAIL ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLAZA CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: JOHNSON & JOHNSON CENTRAL INDEX KEY: 0000200406 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 221024240 STATE OF INCORPORATION: NJ FISCAL YEAR END: 0101 BUSINESS ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 BUSINESS PHONE: 732-524-2455 MAIL ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 4 1 doc4.xml X0306 4 2022-04-21 0000200406 JOHNSON & JOHNSON JNJ 0001904791 Hait William ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933 1 See Remarks Common Stock 2022-04-21 4 M 0 29699.0000 90.4400 A 109935.0000 D Common Stock 2022-04-21 4 S 0 100.0000 183.5770 D 109835.0000 D Common Stock 2022-04-21 4 S 0 100.0000 183.5770 D 109735.0000 D Common Stock 2022-04-21 4 S 0 225.0000 183.5770 D 109510.0000 D Common Stock 2022-04-21 4 S 0 700.0000 183.5770 D 108810.0000 D Common Stock 2022-04-21 4 S 0 1403.0000 183.5770 D 107407.0000 D Common Stock 2022-04-21 4 S 0 1696.0000 183.5770 D 105711.0000 D Common Stock 2022-04-21 4 S 0 2884.0000 183.5770 D 102827.0000 D Common Stock 2022-04-21 4 S 0 22591.0000 183.5770 D 80236.0000 D Employee Stock Options (Right to Buy) 90.4400 2022-04-21 4 M 0 29699.0000 0.0000 D 2017-02-11 2024-02-09 Common Stock 29699.0000 29698.0000 D This transaction was executed in multiple trades at prices ranging from 183.57 to 183.64. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Title: Executive Vice President, Chief External Innovation, Medical Safety and Global Public Health Officer Raavi Deol, as attorney-in-fact for William Hait 2022-04-25